5.80 -0.15 (-2.52%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
5.7
Today’s High
6
52 Week Low
5.47
52 Week High
15.14
Key Metrics
- Market Cap (In Cr) 58.54
- Beta 1.46
- Div. Yield (%) 0
- P/B 2.06
- TTM P/E 40.65
- Peg Ratio -0
- Sector P/E 20.77
- D/E 0.4
Analysis
Price Analysis
-
1 Week-3.25%
-
3 Months-4.29%
-
6 Month-15.86%
-
YTD-4.8%
-
1 Year-50.38%
Recos
0 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 74.04
- Selling/ General/ Admin Expenses Total
- 5.47
- Depreciation/ Amortization
- 0.97
- Other Operating Expenses Total
- 1.61
- Total Operating Expense
- 72.06
- Operating Income
- 1.97
- Net Income Before Taxes
- 1.46
- Net Income
- 1.05
- Diluted Normalized EPS
- 0.18
- Period
- 2022
- Total Assets
- 29.02
- Total Liabilities
- 12.64
- Total Equity
- 16.38
- Tangible Book Valueper Share Common Eq
- 2.89
- Period
- 2022
- Cashfrom Operating Activities
- 3.68
- Cashfrom Investing Activities
- -1.9
- Cashfrom Financing Activities
- -1.97
- Net Changein Cash
- -0.19
- Period
- 2021
- Total Revenue
- 51.04
- Selling/ General/ Admin Expenses Total
- 5.17
- Depreciation/ Amortization
- 0.44
- Other Operating Expenses Total
- 1.34
- Total Operating Expense
- 49.97
- Operating Income
- 1.07
- Net Income Before Taxes
- 0.5
- Net Income
- 0.37
- Diluted Normalized EPS
- 0.07
- Period
- 2021
- Total Assets
- 28.03
- Total Liabilities
- 12.38
- Total Equity
- 15.65
- Tangible Book Valueper Share Common Eq
- 2.76
- Period
- 2021
- Cashfrom Operating Activities
- 1.16
- Cashfrom Investing Activities
- -3.41
- Cashfrom Financing Activities
- 2.37
- Net Changein Cash
- 0.12
- Period
- 2020
- Total Revenue
- 40.03
- Selling/ General/ Admin Expenses Total
- 3.17
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 0.85
- Total Operating Expense
- 39.28
- Operating Income
- 0.75
- Net Income Before Taxes
- 0.48
- Net Income
- 0.35
- Diluted Normalized EPS
- 0.06
- Period
- 2020
- Total Assets
- 23.07
- Total Liabilities
- 7.18
- Total Equity
- 15.89
- Tangible Book Valueper Share Common Eq
- 3
- Period
- 2020
- Cashfrom Operating Activities
- -4.38
- Cashfrom Investing Activities
- 0.47
- Cashfrom Financing Activities
- 3.3
- Net Changein Cash
- -0.61
- Period
- 2019
- Total Revenue
- 39.72
- Selling/ General/ Admin Expenses Total
- 0.72
- Depreciation/ Amortization
- 0.3
- Other Operating Expenses Total
- 1.98
- Total Operating Expense
- 39.47
- Operating Income
- 0.24
- Net Income Before Taxes
- 0.47
- Net Income
- 0.41
- Diluted Normalized EPS
- 0.11
- Period
- 2019
- Total Assets
- 18.25
- Total Liabilities
- 6.09
- Total Equity
- 12.16
- Tangible Book Valueper Share Common Eq
- 3.14
- Period
- 2019
- Cashfrom Operating Activities
- -2.79
- Cashfrom Investing Activities
- -0.65
- Cashfrom Financing Activities
- -1.12
- Net Changein Cash
- -4.57
- Period
- 2018
- Total Revenue
- 42.37
- Selling/ General/ Admin Expenses Total
- 0.88
- Depreciation/ Amortization
- 0.31
- Other Operating Expenses Total
- 2.88
- Total Operating Expense
- 41.77
- Operating Income
- 0.61
- Net Income Before Taxes
- 0.49
- Net Income
- 0.39
- Diluted Normalized EPS
- 0.1
- Period
- 2018
- Total Assets
- 19.31
- Total Liabilities
- 8.37
- Total Equity
- 10.94
- Tangible Book Valueper Share Common Eq
- 2.97
- Period
- 2018
- Cashfrom Operating Activities
- -2.64
- Cashfrom Investing Activities
- -0.46
- Cashfrom Financing Activities
- 8.3
- Net Changein Cash
- 5.2
- Period
- 2017
- Total Revenue
- 28.53
- Selling/ General/ Admin Expenses Total
- 0.59
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 2.91
- Total Operating Expense
- 28.06
- Operating Income
- 0.48
- Net Income Before Taxes
- 0.39
- Net Income
- 0.28
- Diluted Normalized EPS
- 0.07
- Period
- 2017
- Total Assets
- 12.86
- Total Liabilities
- 11.89
- Total Equity
- 0.97
- Tangible Book Valueper Share Common Eq
- 0.26
- Period
- 2017
- Cashfrom Operating Activities
- -2.96
- Cashfrom Investing Activities
- -2.38
- Cashfrom Financing Activities
- 5.36
- Net Changein Cash
- 0.02
- Period
- 2022-09-30
- Total Revenue
- 10.29
- Selling/ General/ Admin Expenses Total
- 0.46
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 1.02
- Total Operating Expense
- 9.96
- Operating Income
- 0.33
- Net Income Before Taxes
- 0.2
- Net Income
- 0.16
- Diluted Normalized EPS
- 0.03
- Period
- 2022-09-30
- Total Assets
- 27.41
- Total Liabilities
- 10.55
- Total Equity
- 16.86
- Tangible Book Valueper Share Common Eq
- 2.97
- Period
- 2022-09-30
- Period
- 2022-06-30
- Total Revenue
- 12.31
- Selling/ General/ Admin Expenses Total
- 0.52
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 0.73
- Total Operating Expense
- 11.8
- Operating Income
- 0.51
- Net Income Before Taxes
- 0.42
- Net Income
- 0.32
- Diluted Normalized EPS
- 0.06
- Period
- 2022-06-30
- Total Assets
- 26
- Total Liabilities
- 9.3
- Total Equity
- 16.7
- Tangible Book Valueper Share Common Eq
- 2.94
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 20.51
- Selling/ General/ Admin Expenses Total
- 4.23
- Depreciation/ Amortization
- 0.29
- Other Operating Expenses Total
- -1.86
- Total Operating Expense
- 20.37
- Operating Income
- 0.14
- Net Income Before Taxes
- 0.05
- Net Income
- 0.05
- Diluted Normalized EPS
- 0.01
- Period
- 2022-03-31
- Total Assets
- 29.02
- Total Liabilities
- 12.64
- Total Equity
- 16.38
- Tangible Book Valueper Share Common Eq
- 2.89
- Period
- 2022-03-31
- Period
- 2021-12-31
- Total Revenue
- 19.29
- Selling/ General/ Admin Expenses Total
- 0.45
- Depreciation/ Amortization
- 0.34
- Other Operating Expenses Total
- 0.46
- Total Operating Expense
- 18.66
- Operating Income
- 0.63
- Net Income Before Taxes
- 0.55
- Net Income
- 0.41
- Diluted Normalized EPS
- 0.08
- Period
- 2021-12-31
- Total Assets
- 30.91
- Total Liabilities
- 14.12
- Total Equity
- 16.79
- Tangible Book Valueper Share Common Eq
- 2.96
- Period
- 2021-12-31
- Period
- 2021-09-30
- Total Revenue
- 34.24
- Selling/ General/ Admin Expenses Total
- 0.8
- Depreciation/ Amortization
- 0.48
- Other Operating Expenses Total
- 2.88
- Total Operating Expense
- 33.04
- Operating Income
- 1.2
- Net Income Before Taxes
- 0.86
- Net Income
- 0.59
- Diluted Normalized EPS
- 0.11
- Period
- 2021-09-30
- Total Assets
- 28.79
- Total Liabilities
- 12.41
- Total Equity
- 16.38
- Tangible Book Valueper Share Common Eq
- 2.89
- Period
- 2021-09-30
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Nakoda Group of Industries
- 71.4
- -3.05
- -4.1
- 261.36
- 73.15
- 81.95
- The Peria Karamalai Tea & Pro Co
- 0
- 0
- 0
- 0
- 0
- 77.18
- Ajooni Biotech
- 0
- 0
- 0
- 0
- 0
- 58.54
- Sanwaria Consumer
- 0.64
- -0.02
- -3.03
- 1.55
- 0.65
- 47.85
- Dharani Sugars & Chemicals
- 10.6
- -0.3
- -2.75
- 23.45
- 9.91
- 36.19
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Nakoda Group of Industries
- 47.11
- 5.09
- -
- -
- The Peria Karamalai Tea & Pro Co
- 347.15
- 0.42
- 2.08
- 6.77
- Ajooni Biotech
- 33.48
- 2.06
- 4.05
- 1.04
- Sanwaria Consumer
- -
- -
- -4334.77
- -7.49
- Dharani Sugars & Chemicals
- -
- -
- -
- -34.83
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 63.61%
- 55,729,473
- Others
- 34.77%
- 30,466,397
- MADHUKAR SHETH
- 1.2%
- 1,050,000
- Others
- 16.12%
- 14,126,861
- NAVRATRI SHARE TRADING PRIVATE LIMITED
- 2.14%
- 1,876,851
- MONIFEST CAPITAL PRIVATE LIMITED
- 1.23%
- 1,075,150
- PRITIKA INDUSTRIES LTD
- 1.12%
- 977,775
- Others
- 2.46%
- 2,156,197
- HUF
- 3.11%
- 2,723,452
- Clearing member
- 0.05%
- 44,880
- Others
- 1.4%
- 1,223,540
- Others
- 0.01%
- 8,370
- Promoter & Promoter Group Shareholding
- 36.39%
- 31,884,248
- JASJOT SINGH
- 20.03%
- 17,549,746
- UPNEET KAUR
- 5.89%
- 5,159,727
- ASHMEET KAUR
- 3.63%
- 3,178,802
- PARMJEET KAUR
- 3.63%
- 3,178,802
- ISHNEET KAUR
- 0.61%
- 532,927
- HEALTHY BIOSCIENCES PRIVATE LIMITED
- 2.61%
- 2,284,244
- Bodies Corporate
- 2.61%
- 2,284,244
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 11-Nov-22
- Quarterly Results
- 17-Oct-22
- Others
- 05-Aug-22
- Quarterly Results
- 09-May-22
- Audited Results
- 11-Feb-22
- Quarterly Results
- 13-Nov-21
- Quarterly Results
- 02-Aug-21
- Quarterly Results
- 23-Jun-21
- Audited Results
- 13-Mar-21
- Allotment of bonus shares
- 01-Mar-21
- Others
No recent AGMs.
No recent dividend announcements.
- Announced on
- Record Date
- Ex-Bonus
- Description
- 23-Jan-21
- 12-Mar-21
- 10-Mar-21
- Bonus issue in the ratio of 1:9 of Rs. 10/-.
- Ex-Splits
- Old FV
- New FV
- Description
- 07-Oct-22
- 10
- 2
- Stock split from Rs. 10/- to Rs. 2/-.
- Announced on
- Record Date
- Ex-Rights Date
- Ratio
- FV
- Premium
- Description
- 02-Aug-21
- 25-Nov-22
- 25-Nov-22
- 29:30
- 2
- 4
- Rights issue of equity shares of Rs. 2/- in the ratio of 29:30 @ premium of Rs. 4/-.
Company Profile
ABOUT Ajooni Biotech
- Industry Food Processing
- ISIN INE820Y01021
- NSE Code AJOONI
Ajooni Biotech Limited is an India-based animal health care solutions company. The Company is engaged in the manufacturing of compounded animal feed and feed supplements in India. Its portfolio offers a range of cattle feed, cattle feed chips, camel feed, cotton oil cake, mustard oil cake and feed supplements to cover the entire life cycle of an animal. Its high energy balanced cattle feed includes calf starter, heifer, dairy calf grower, low yield cattle, basic milking cattle and high yield cattle. The Company's cattle feeds include Autus DIAMOND WONDER, Autus NURTURE CALF STARTER, Autus WINNER, Autus HIFFER /GROWER, Autus ENERGY PLUS, Autus ECO and Autus BUFF POWER. Its feed supplements include liquid calcium, liver tonic, mineral mixture, ultra-tonic, digestive powder and multi vitamins. The Company's feed supplements include CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, AUTOVITA and others.
MANAGEMENT
- Charanjit Singh Chief Financial Officer
- Sandeep Goyal Compliance Officer, Company Secretary
- Jasjot Singh Managing Director, Executive Director
- Partek Singh Executive and Non Independent Director
Company Summary
AJOONI BIOTECH SUMMARY
Ajooni Biotech is trading 0% at Rs as compared to its last closing price. Ajooni Biotech has given -4.8% in this year & -3.25% in the last 5 days.
Ajooni Biotech has TTM P/E ratio 40.65 as compared to the sector P/E of 20.77.
The company posted a net profit of 0.16 Crores in its last quarter.
Listed peers of Ajooni Biotech include Nakoda Group of Industries (-4.1%), The Peria Karamalai Tea & Pro Co (0%), Ajooni Biotech (0%) etc.
Ajooni Biotech has a 36.39% promoter holding & 63.61% public holding.
FAQs about Ajooni Biotech
Ajooni Biotech is trading at as on -. This is 0% as compared to its previous closing price of -
The market capitalization of Ajooni Biotech is 58.54 Cr as on -.
The 52 wk high for Ajooni Biotech is - whereas the 52 wk low is -
Ajooni Biotech can be analyzed on the following key metrics -
- TTM P/E: 40.65
- Sector P/E: 20.77
- Dividend Yield: 0%
- D/E ratio: -
Ajooni Biotech reported a net profit of 1.05 Cr in 2022.
